NDC 0404-9844
Infant Dextrose 250 mg per 1 mL injection, solution
On the label: Henry Schein, Inc.. It's repackaged: Henry Schein, Inc. rebottles it from Hospira, Inc.'s NDC 0409-1775.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Hospira, Inc. | Rocky Mount, NC, United States | Makes it, tests it, packages it and labels it | No problems foundFeb 7, 2025 · 11 inspections, 3 with FDA action |
| Roquette America, Inc. | Keokuk, IA, United States | Makes the active ingredient | Problems found, fixed voluntarilyJan 30, 2026 · 5 inspections |
Recalls
- Nov 27, 2019 · Class II · Pfizer Inc.
Labeling: Incorrect or Missing Lot and/or expiration date.
Lots: Lot #: 80-292-EV, 1AUG2019 on carton. Expiration date printed on syringe is 1AUG2021 which is incorrect. - Apr 21, 2017 · Class I · Hospira Inc.
Presence of Particulate Matter: human hair found within an internal sample syringe.
Lots: Lot 58382EV*, Exp 1OCT 2017, *lot may be followed by 01 or 02
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Anhydrous Dextrose: every company that makes it
- Form
- injection, solution, intravenous
- Strength
- 250 mg per 1 mL
- Approval
- NDA NDA019445
- On the market since
- Jan 10, 2022
- Package NDCs
0404-9844-10- Official label
- DailyMed (National Library of Medicine), updated Jul 13, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?